Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors
Publication
, Conference
Vaduganathan, M; Greene, SJ; Zhang, S; Chiswell, K; Devore, AD; Butler, J; Heidenreich, PA; Huang, J; Kittleson, MM; Maddox, KEJ
Published in: CIRCULATION
2021
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2021
Volume
144
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Vaduganathan, M., Greene, S. J., Zhang, S., Chiswell, K., Devore, A. D., Butler, J., … Maddox, K. E. J. (2021). Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors. In CIRCULATION (Vol. 144).
Vaduganathan, Muthiah, Stephen J. Greene, Shuaiqi Zhang, Karen Chiswell, Adam D. Devore, Javed Butler, Paul A. Heidenreich, Joanna Huang, Michelle M. Kittleson, and Karen E Joynt Maddox. “Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors.” In CIRCULATION, Vol. 144, 2021.
Vaduganathan M, Greene SJ, Zhang S, Chiswell K, Devore AD, Butler J, et al. Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors. In: CIRCULATION. 2021.
Vaduganathan, Muthiah, et al. “Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors.” CIRCULATION, vol. 144, 2021.
Vaduganathan M, Greene SJ, Zhang S, Chiswell K, Devore AD, Butler J, Heidenreich PA, Huang J, Kittleson MM, Maddox KEJ. Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors. CIRCULATION. 2021.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2021
Volume
144
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology